ArticleJournal of inflammation research2025
Ethyl Acetate Extract of
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gut microbiota in acute lung injury/acute respiratory distress syndrome: mechanistic insights and therapeutic opportunities via the gut-lung axis.Frontiers in cellular and infection microbiology · 2026Review
- Qingwen Hufei Granules Attenuate Lipopolysaccharide-Induced Acute Lung Injury by Suppressing NLRP3 Inflammasome-Dependent Pyroptosis.Journal of inflammation research · 2025Article
- Qingfei Dayuan granules and decoction alleviate acute lung injury via TLR4 signaling pathway modulation, gut microbiota regulation, and metabolic reprogramming.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Acute lung injury (ALI) is a serious clinical respiratory disease, but there are few effective drugs for ALI. As a natural product, Methods: By multiple bioinformatics analysis, AGER and ITGB2 were found to be the potential target genes of EBEE against oxidative stress in ALI. Different doses of EBEE were feed into ALI mice in vivo (600 mg/kg bw, 200 mg/kg bw) and .RAW 264.7 cells (100 μg/mL, 25 μg/mL) in vitro to evaluate the protection function. Western Blot, immunofluorescence and biochemical factor detection were used to measure the levels of oxidative stress associated factors, and gut microbiota analysis examined the gut microbiota in mice. Results: EBEE, which contained a total of 1374 components, was identified as the most active against oxidative stress. The EBEE treatment most significantly downregulated the ROS, MDA and pathological damages. AGER and ITGB2 were picked up as target genes of EBEE against ALI by bioinformatics. In vitro and in vivo, AGER, NOX4, and P-GSK3β expression levels were significantly decreased, and ITGB2, P-AKT, NRF2 and HO-1 were significantly up-regulated throughout EBEE treatment. By consuming EBEE, Conclusion: EBEE treatment significantly ameliorated the pathological damage and oxidative stress by regulating AGER, ITGB2 and related pathways in vitro and in vivo. Furthermore, EBEE treatment improved the composition of the gut microbiota in ALI mice. These data suggested that EBEE could be used as a potential functional food for prevention and treatment of ALI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.